Larvol Delta - A-First-in-Human-Study-of-AX202-in-Healthy-Subjects-and-Patients-With-Psoriasis

AX-202 - Arxx Therap, Cancer Research UK

http://clinicaltrials.gov/ct2/show/NCT05965089

Sep 28, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next